Skip to main content

Doing now what patients need next

Pioneering diagnostics and pharma to create a healthier future for everyone

A family gathers around an outdoor table, enjoying a meal. A man hugs a smiling boy, while two women sit nearby, all appearing content and joyful.

In the spotlight

Roche publishes its half year results for 2026

Roche reports +6% (CER) sales growth in the first six months of 2026. Commenting on the results, CEO Thomas Schinecker said: “Our strong momentum continued in the first half of the year, driven by a 6% sales increase at constant exchange rates and significant positive pipeline development.

How we improved outcomes for patients around the world

With our combined strengths in Diagnostic and Pharmaceuticals, we worked to provide real and positive change for patients, the people they love and the professionals who care for them. Discover the highlights in our Annual Report.

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Investor information

Sales by HY 2026

CHF 30.4 billion

Finance Information Tool
Dividend Yield for FY 2025

3.2%

Share and Bond Information
Next Report

22 October 2026

Reporting

We are Roche

We combine life-changing diagnostics and medicines to take on the toughest healthcare challenges, those that place the greatest strain on patients, families, communities, and health systems. 

Guided by the experiences of patients, we are determined to prevent, stop and cure diseases so people can live healthier, longer lives.

Man holding a surfing board smiling with a ocean in the background.

Our mission in action

  • Two colleagues sit on a green couch in a modern office, engaged in conversation. One person gestures while speaking, and the other listens attentively with a slight smile.
    Prevent

    Identifying high-risk patients

    We prevent diseases by identifying high-risk patients early to enable timely use of medicines.

    Our strategy
  • A laboratory scientist wearing safety glasses and gloves looks into a microscope while conducting research in a lab setting.
    Stop

    Halting disease progression

    We stop disease progression by accurately diagnosing patients and delivering targeted medicines.

    Our diagnostics solutions
  • A laboratory professional wearing glasses and gloves explains a piece of equipment to a colleague while holding its open lid in a lab setting.
    Cure

    Restoring health through medicines

    We cure diseases by identifying the cause of a patient’s condition and restoring health through curative medicines.

    Our pharma solutions

Read our stories

Decorative Illustration

Transforming autoimmune treatment: How data-driven therapies are changing patient outcomes

Three diseases. One mission. Roche combines breakthrough technologies with deep immunology expertise and real-world data to transform treatment for lupus, IBD, and COPD

Decorative illustration

Haemophilia treatment for all: A partnership for better access

The Humanitarian Aid Program, a landmark initiative led by the World Federation of Hemophilia (WFH) and supported by partners including Roche, is working to ensure that people with bleeding disorders in developing countries can access the diagnosis, treatment and care they need.

Shape the future of healthcare

Join our global team of innovators, scientists, and changemakers

A gloved hand holds a petri dish with gold-colored bacterial colonies on a reddish-brown medium, suggesting a laboratory experiment.

About Roche

We unite leading science and technology across diagnostics, medicines, and digital solutions to prevent, stop and cure diseases.

Abstract close-up of geometric shapes with vibrant pink and orange hues. A pattern of glowing circles creates an energetic and modern feel.

Solutions

We are committed to tackling the most complex healthcare challenges that place the greatest strain on people and societies worldwide.

3D Insights into Novel Cancer Models.

Innovation

In everything we do, we are guided by the needs of patients and their loved ones, acting with integrity, courage and passion.

Close-up of a microplate with multiple wells, each being filled by thin metallic pipettes. The setting is a laboratory environment, conveying precision.

Media

Access a wide range of materials relating to our company, our people, innovation, solutions and diagnostics tools or get in touch with us.

Modern indoor space with large windows, wooden walls, and hanging lights. Curved planter with lush green ferns and plants creates a refreshing atmosphere.

Investors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.